# Prospective Analysis of Hypersensitivity Reactions to Oxaliplatin

> **NCT00831571** · — · COMPLETED · sponsor: **Dana-Farber Cancer Institute** · enrollment: 112 (actual)

## Conditions studied

- Colorectal Cancer
- Esophageal Cancer
- Gastric Cancer
- Small Bowel Cancer
- Pancreatic Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00831571
- **Lead sponsor:** Dana-Farber Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2012-12
- **Final completion:** 2022-04
- **Target enrollment:** 112 (ACTUAL)
- **Last updated:** 2022-04-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00831571

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00831571, "Prospective Analysis of Hypersensitivity Reactions to Oxaliplatin". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00831571. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*